These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37246821)

  • 1. Spectrum of Liver Pathology in Dyskeratosis Congenita.
    Putra J; Agarwal S; Al-Ibraheemi A; Alomari AI; Perez-Atayde AR
    Am J Surg Pathol; 2023 Aug; 47(8):869-877. PubMed ID: 37246821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dyskeratosis congenita associated with leukoplakia of the tongue.
    Noto Z; Tomihara K; Furukawa K; Noguchi M
    Int J Oral Maxillofac Surg; 2016 Jun; 45(6):760-3. PubMed ID: 26778687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dyskeratosis congenita with portal hypertension of unknown etiology.
    Redkar NN; Pandey DB; Jerajani HR; Padhiyar R; Dhokare A
    J Assoc Physicians India; 2011 Apr; 59():260-3. PubMed ID: 21755768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic Angiosarcoma with Dyskeratosis Congenita.
    Horiguchi N; Kakizaki S; Iizuka K; Hagiwara S; Ohyama T; Yamazaki Y; Shibusawa N; Sato K; Kusano M; Nakazato Y; Yamada M
    Intern Med; 2015; 54(22):2867-72. PubMed ID: 26568000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita.
    Callea M; Martinelli D; Cammarata-Scalisi F; Grimaldi C; Jilani H; Grimaldi P; Willoughby CE; Morabito A
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of liver disease and portal hypertension in dyskeratosis congenita and related telomere biology disorders.
    Vittal A; Niewisch MR; Bhala S; Kudaravalli P; Rahman F; Hercun J; Kleiner DE; Savage SA; Koh C; Heller T; Giri N
    Hepatology; 2023 Dec; 78(6):1777-1787. PubMed ID: 37184208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Transplant for Management of Hepatic Complications of Dyskeratosis Congenita: A Case Report.
    Alebrahim M; Akateh C; Arnold CA; Benissan-Messan D; Chavez JA; Singh N; Al-Adwan Y; El-Hinnawi A; Michaels A; Black SM
    Exp Clin Transplant; 2022 Jul; 20(7):702-705. PubMed ID: 33272154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral and dental phenotype of dyskeratosis congenita.
    Atkinson JC; Harvey KE; Domingo DL; Trujillo MI; Guadagnini JP; Gollins S; Giri N; Hart TC; Alter BP
    Oral Dis; 2008 Jul; 14(5):419-27. PubMed ID: 18938267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in dyskeratosis congenita.
    Nishio N; Kojima S
    Int J Hematol; 2010 Oct; 92(3):419-24. PubMed ID: 20882440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver failure due to hepatic angiosarcoma in an adolescent with dyskeratosis congenita.
    Olson TS; Chan ES; Paessler ME; Sullivan KE; Frantz CN; Russo P; Bessler M
    J Pediatr Hematol Oncol; 2014 May; 36(4):312-5. PubMed ID: 23588325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence analysis of the shelterin telomere protection complex genes in dyskeratosis congenita.
    Savage SA; Giri N; Jessop L; Pike K; Plona T; Burdett L; Alter BP
    J Med Genet; 2011 Apr; 48(4):285-8. PubMed ID: 21209122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyskeratosis congenita.
    Savage SA; Alter BP
    Hematol Oncol Clin North Am; 2009 Apr; 23(2):215-31. PubMed ID: 19327580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Research progress of dyskeratosis congenita].
    Wang F; Du YQ; Gong W; Sun CK; Zeng X
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2019 Feb; 54(2):130-134. PubMed ID: 30695916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Squamous cell carcinoma of the tongue in 5-year-old girl with dyskeratosis congenita.
    Jh K; Cs K
    Int J Oral Maxillofac Surg; 2021 Dec; 50(12):1546-1549. PubMed ID: 33736925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dyskeratosis congenita: an update].
    Mialou V; Leblanc T; Peffault de Latour R; Dalle JH; Socié G
    Arch Pediatr; 2013 Mar; 20(3):299-306. PubMed ID: 23352883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver transplantation in precirrhotic biliary tract disease: Portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy.
    Abraham SC; Kamath PS; Eghtesad B; Demetris AJ; Krasinskas AM
    Am J Surg Pathol; 2006 Nov; 30(11):1454-61. PubMed ID: 17063088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report.
    Ratnasamy V; Navaneethakrishnan S; Sirisena ND; Grüning NM; Brandau O; Thirunavukarasu K; Dagnall CL; McReynolds LJ; Savage SA; Dissanayake VHW
    BMC Med Genet; 2018 May; 19(1):85. PubMed ID: 29801475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dyskeratosis congenital: clinical features and genotype analysis in two Chinese patients].
    Liu R; Shi XD; Wang TY; Liu ZQ; Hu T; Fan W; Cao J; Hou R; Liang C; Huang SA
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):684-7. PubMed ID: 22339828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Squamous cell carcinoma of the tongue in a patient with dyskeratosis congenita: a rare entity.
    Fatehi KS; Thiagarajan S; Dhar H; Chaukar D; DCruz AK
    Br J Oral Maxillofac Surg; 2019 Jan; 57(1):79-81. PubMed ID: 30587389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of dyskeratosis congenita with portal hypertension associated with jugular venous anomaly.
    Yazgan Y; Demirtürk L; Ozel M; Başekim C
    Turk J Gastroenterol; 2006 Mar; 17(1):66-9. PubMed ID: 16830282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.